»
Commercializing the Stem Cell Sciences
 
 

Commercializing the Stem Cell Sciences, 1st Edition

 
Commercializing the Stem Cell Sciences, 1st Edition,O Harvey,ISBN9781907568602
 
 
 

  

Woodhead Publishing

9781907568602

9781908818140

212

Print Book + eBook

USD 204.00
USD 340.00

Buy both together and save 40%

Print Book

Hardcover

In Stock

Estimated Delivery Time
USD 170.00

eBook
eBook Overview

DRM Free included formats: EPub, Mobi, PDF

VST format:

USD 170.00
Add to Cart
 
 

Key Features

  • In-depth discussion of case studies of products undergoing development
  • Focus on commercial optimization of stem cell treatments
  • Analysis in a global context and covering a diverse range of countries

Description

Promising new developments in biomedical technology such as stem cell science are widely endorsed by governments keen to reduce spiralling healthcare costs, clinicians focused on patient care, and patients demanding revolutionary new treatments. Commercializing the stem cell sciences offers a comparative analysis of the commercial methods adopted in the global stem cell industries. It seeks to establish whether there is an optimum commercial model and to examine what emerging companies can learn from their predecessors. Following an introduction to stem cell sciences and the problems involved in their commercialization, the book begins with a discussion of stem cell treatments from a global perspective, and the role of innovation in the commercialization of biotechnology in general. In the second half of the book, chapters focus on the different strategies that can be employed and their relative risks and values, before a conclusion that looks at potential new developments in the field.

O Harvey

Dr Olivia Harvey is currently a Visiting Fellow with the Biopolitics of Science Research Network at the University of Sydney, Australia. She was previously a Faculty of Arts and Social Sciences Postdoctoral Research Fellow and Research Fellow in the School of History and Philosophy at the University of New South Wales, and an Economic and Social Research Council Postdoctoral Research Fellow and Research Fellow with the Global Biopolitics Research Group (formerly of the University of East Anglia), Centre for Biomedicine and Society (now at Brunel University), King’s College, London.

Affiliations and Expertise

University of Sydney, Australia

Commercializing the Stem Cell Sciences, 1st Edition

Introduction: Stem cell science, biotechnology and the problem of commercialization; Stem cell treatments in a global marketplace; The role of innovation systems in the commercialization of biotechnology; Low-risk, low-value: Adult stem cells; High-risk, high-value: Embryonic stem cells; Low-risk, low-value: iPS cells; What does the future hold?
 
 
Free Shipping
Shop with Confidence

Free Shipping around the world
▪ Broad range of products
▪ 30 days return policy
FAQ